JPH11137212A - Beauty culture composition - Google Patents
Beauty culture compositionInfo
- Publication number
- JPH11137212A JPH11137212A JP9329671A JP32967197A JPH11137212A JP H11137212 A JPH11137212 A JP H11137212A JP 9329671 A JP9329671 A JP 9329671A JP 32967197 A JP32967197 A JP 32967197A JP H11137212 A JPH11137212 A JP H11137212A
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- cosmetic
- skin
- theanine
- drink
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 230000003796 beauty Effects 0.000 title claims abstract description 11
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims abstract description 34
- 239000002537 cosmetic Substances 0.000 claims abstract description 32
- 150000001875 compounds Chemical class 0.000 claims abstract description 19
- 229940026510 theanine Drugs 0.000 claims abstract description 17
- 102000008186 Collagen Human genes 0.000 claims abstract description 15
- 108010035532 Collagen Proteins 0.000 claims abstract description 15
- 229920001436 collagen Polymers 0.000 claims abstract description 15
- 235000013305 food Nutrition 0.000 claims abstract description 13
- WGXUDTHMEITUBO-YFKPBYRVSA-N glutaurine Chemical compound OC(=O)[C@@H](N)CCC(=O)NCCS(O)(=O)=O WGXUDTHMEITUBO-YFKPBYRVSA-N 0.000 claims abstract description 13
- 229950001776 glutaurine Drugs 0.000 claims abstract description 13
- 235000013361 beverage Nutrition 0.000 claims description 8
- JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 claims description 2
- 230000037303 wrinkles Effects 0.000 abstract description 7
- 230000032683 aging Effects 0.000 abstract description 5
- 150000001408 amides Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 239000012153 distilled water Substances 0.000 description 18
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 16
- 230000000694 effects Effects 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 9
- 229930003451 Vitamin B1 Natural products 0.000 description 9
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 9
- 230000002500 effect on skin Effects 0.000 description 9
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 9
- 229950001574 riboflavin phosphate Drugs 0.000 description 9
- 229960003495 thiamine Drugs 0.000 description 9
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 9
- 235000010374 vitamin B1 Nutrition 0.000 description 9
- 239000011691 vitamin B1 Substances 0.000 description 9
- 229940089133 vitamin b6 5 mg Drugs 0.000 description 9
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 8
- 229960000367 inositol Drugs 0.000 description 8
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 8
- 229960003966 nicotinamide Drugs 0.000 description 8
- 235000005152 nicotinamide Nutrition 0.000 description 8
- 239000011570 nicotinamide Substances 0.000 description 8
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 229940072552 royal jelly 200 mg Drugs 0.000 description 6
- 238000007665 sagging Methods 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 229960001948 caffeine Drugs 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 241000700198 Cavia Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- VVIUBCNYACGLLV-UHFFFAOYSA-N hypotaurine Chemical compound [NH3+]CCS([O-])=O VVIUBCNYACGLLV-UHFFFAOYSA-N 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 3
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- -1 auxiliaries Substances 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940006423 chondroitin sulfate sodium Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000004066 metabolic change Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229940045613 taurine 1000 mg Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
Landscapes
- Non-Alcoholic Beverages (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、美容組成物に関す
るものであり、更に詳細には、優れた美容効果を有する
化粧料タイプ及び/又は飲食品タイプの美容組成物に関
する。本発明によればしわの改善等の優れた美肌効果が
奏されるので、肌のはりを保ち、外側からだけではなく
身体の内側からも効果を発揮する化粧料や美容飲料を製
造することができる。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic composition, and more particularly to a cosmetic composition and / or a food and beverage type cosmetic composition having an excellent cosmetic effect. According to the present invention, an excellent skin effect such as improvement of wrinkles is exerted, so that it is possible to produce a cosmetic or a beauty beverage that maintains the skin swelling and exerts the effect not only from the outside but also from the inside of the body. it can.
【0002】[0002]
【従来の技術】従来より、しわやたるみは、しみ、そば
かすと並び、皮膚の美容上の大きな問題点とされてき
た。しわやたるみは、皮膚の老化の代表的な外観の変化
であり、それは老化とともに確実に進行する不可逆的な
現象とされてきた。そして、皮膚の乾燥や紫外線の影響
は、その現象に拍車をかけ、更に悪化させる大きな要因
となってきている。しわやたるみの原因は繊維芽細胞の
加齢、老化に伴う代謝変化に起因する内的要因と、紫外
線、活性酸素等によるダメージの蓄積に起因する外的要
因により細胞外マトリックスの質的、量的変化とされて
いるが、これらのメカニズムは複雑に絡み合っており、
未だその解決にいたる決定的な手段は皆無といってよ
い。2. Description of the Related Art Conventionally, wrinkles and sagging have been regarded as a major problem in skin cosmetics, along with spots and freckles. Wrinkling and sagging are changes in the appearance of skin aging, which has been described as an irreversible phenomenon that reliably progresses with aging. The effects of skin dryness and ultraviolet rays have spurred the phenomenon and have become a major factor that further exacerbates the phenomenon. The cause of wrinkles and sagging is the qualitative and quantity of extracellular matrix due to internal factors caused by metabolic changes accompanying aging and aging of fibroblasts and external factors caused by accumulation of damage due to ultraviolet rays, active oxygen, etc. But these mechanisms are intricately intertwined,
There is still no definitive solution to the solution.
【0003】[0003]
【発明が解決しようとする課題】本発明者らは、上記の
ような事情に鑑み、皮膚の恒常的維持を達成し得る美容
組成物を新たに開発することとした。SUMMARY OF THE INVENTION In view of the above-mentioned circumstances, the present inventors have newly developed a cosmetic composition which can achieve the constant maintenance of the skin.
【0004】[0004]
【課題を解決するための手段】本発明者らは、上記の課
題を解決するために鋭意研究を重ね、化粧料、美容飲料
においてグルタミルアミド化合物を配合したところ、よ
り強力な美肌効果を得られることを見出し、この知見に
基ずいて本発明を完成するに至った。Means for Solving the Problems The present inventors have conducted intensive studies in order to solve the above-mentioned problems, and when a glutamylamide compound is blended in cosmetics and beauty drinks, a stronger skin effect can be obtained. This led to the completion of the present invention based on this finding.
【0005】すなわち、本発明は、下記化2で示される
一般式(I)の化合物を含有することを特徴とする美肌
組成物である。本組成物は、優れた美肌効果を奏する点
で非常にすぐれているが、特に、その美肌効果が外用の
みでなく内用によっても奏される点で特徴的である。[0005] That is, the present invention is a beautiful skin composition comprising a compound represented by the following general formula (I). The present composition is very excellent in that it has an excellent skin effect, but is particularly characterized in that the skin effect is exhibited not only for external use but also for internal use.
【0006】[0006]
【化2】 Embedded image
【0007】以下、本発明について詳述する。先述のよ
うに、皮膚のしわ、たるみは外的、あるいは内的な要因
が複雑に絡み合って起こる現象であり、メカニズムの解
明が困難であった。Hereinafter, the present invention will be described in detail. As described above, wrinkles and sagging of the skin are phenomena caused by intricately entangled external or internal factors, and it has been difficult to elucidate the mechanism.
【0008】本発明者らは、グルタミルアミド化合物の
恒常性維持作用、細胞増殖促進作用、肌色改善作用に着
目し、数多くの化合物について、また、それらの誘導
体、関連化合物について各種スクリーニングを行なった
結果、強力な美肌効果を有する化合物(I)を発見し
た。そして更に検討の結果、化合物(I)は、皮膚外用
に適用しても、また、内服により経口的に投与しても強
力な美肌効果を有するというきわめて有用な新知見を得
た。The present inventors focused on the homeostasis-preserving action, cell-proliferation-promoting action, and skin-color-improving action of glutamylamide compounds, and conducted various screenings on a large number of compounds, their derivatives, and related compounds. , A compound (I) having a strong beautiful skin effect. Further, as a result of further investigation, a very useful new finding that the compound (I) has a strong skin beautiful effect even when applied externally to the skin or when orally administered by oral administration has been obtained.
【0009】これらの化合物は、後述する試験例からも
明らかなように、優れた恒常性維持作用を有し、さらに
しわやたるみの基となる細胞外マトリックスの変化に影
響を与える皮膚の繊維芽細胞の増殖を促進する効果を有
し、これを化粧料、および美容用飲食品に使用すれば、
外側、内側から優れた美肌作用を発揮することが出来
る。As is clear from the test examples described later, these compounds have an excellent homeostasis-maintaining effect, and furthermore, the fibroblasts of the skin which affect the change of the extracellular matrix which is the basis of wrinkles and sagging Has the effect of promoting cell proliferation, if this is used in cosmetics, and beauty foods and drinks,
Excellent skin effect from outside and inside.
【0010】次に、本発明の化合物の恒常性維持作用と
細胞増殖促進効果について、試験例を記す。Next, test examples are given for the homeostasis-maintaining effect and the cell growth-promoting effect of the compound of the present invention.
【0011】(試験例1) (恒常性維持効果)試験動物は、5週齢の雌性モルモッ
ト(Crj:Hartley,SPF,体重300〜3
50g)を購入し、1週間の予備飼育の後、実験に用い
た。飼育条件は、22±1℃、湿度55±10%、換気
回数20回/時間、照明時間12時間/日(午前6時点
灯、午後6時消灯)に設定された飼育室で、金属ケージ
(15×30×17cm)にて個別飼育とした。飼料
は、固型飼料RC4(オリエンタル酵母工業(株))を
用い、飲料水は給水瓶にて公共水道水をそれぞれ自由に
摂取させた。(Test Example 1) (Homeostasis maintaining effect) A test animal was a 5-week-old female guinea pig (Crj: Hartley, SPF, body weight 300 to 3).
50 g) was purchased and used for the experiment after one week of preliminary breeding. The breeding conditions were as follows: a breeding room set at 22 ± 1 ° C., a humidity of 55 ± 10%, a ventilation frequency of 20 times / hour, a lighting time of 12 hours / day (lights on at 6:00 am, lights off at 6:00 pm), and a metal cage ( (15 × 30 × 17 cm). As a feed, a solid feed RC4 (Oriental Yeast Co., Ltd.) was used, and drinking water was freely ingested from public tap water using a water bottle.
【0012】モルモットは、1群3匹を用い、7日間の
過密飼育(1匹当たり収容体積1700cm3)により
ストレスを負荷した。ストレス負荷開始前3日から、ス
トレス負荷7日間の計10日間、テアニン2000mg
/kg及びグルタウリン1000mg/kgを連日投与
した。ここに、テアニンは、一般式(I)において、X
=−Hの化合物(L−グルタミン酸−γ−モノエチルア
ミド)であり、グルタウリンは、一般式(I)におい
て、X=−SO3Hの化合物(L−グルタミン酸−γ−
スルホン酸エチルアミド)である。[0013] Guinea pigs were subjected to stress by three- group guinea pigs and overcrowded for 7 days (capacity per animal: 1700 cm 3 ). Theanine 2000mg for a total of 10 days from 3 days before the start of stress loading to 7 days of stress loading
/ Kg and glutaurine 1000 mg / kg were administered daily. Here, theanine is represented by X in the general formula (I).
= -H (L-glutamic acid-γ-monoethylamide), and glutaurine is a compound of the formula (I) where X = —SO 3 H (L-glutamic acid-γ-
Sulfonic acid ethylamide).
【0013】投与日の前日に、モルモットの毛刈りを行
ない、最終日に色彩色差計(ミノルタCR−300)に
て皮膚測定した。得られた結果を、下記表1及び図1に
示す。The day before the administration, the guinea pig was shaved, and the skin was measured on the last day with a colorimeter (Minolta CR-300). The obtained results are shown in Table 1 below and FIG.
【0014】[0014]
【表1】 [Table 1]
【0015】表1、図1の結果から明らかなように、テ
アニン、グルタウリンの投与により、ストレスを負荷し
ても平常時とほぼ同等の色を保った。表1及び図1にお
いて、b*値は黄色味、L*値は明度、a*値は赤みを
表わす数値である。なお、この試験方法及び判定基準
は、日皮会誌:107(5),615−622,199
7(平9)に準じた。As is clear from the results shown in Table 1 and FIG. 1, the administration of theanine and glutaurine maintained almost the same color as in normal times even when stress was applied. In Table 1 and FIG. 1, the b * value is a yellow color, the L * value is lightness, and the a * value is redness. In addition, this test method and criteria are as follows:
7 (Heisei 9).
【0016】(試験例2) (繊維芽細胞増殖促進効果)ヒト皮膚繊維芽細胞は、1
0%の牛胎児血清を添加したイーグルMEM培地にて培
養し、テアニン、グルタウリンをそれぞれ100μg/
mlと300μg/mlに成るように添加した。96時
間培養後、細胞を回収し、細胞数を計数した。結果は図
2に示したように、テアニン、グルタウリンは繊維芽細
胞増殖促進効果を有する事が確認された。(Test Example 2) (Effect of promoting fibroblast proliferation)
The cells were cultured in an Eagle MEM medium supplemented with 0% fetal calf serum, and each of theanine and glutaurine was added in an amount of 100 μg / g.
ml and 300 μg / ml. After culturing for 96 hours, the cells were collected and the number of cells was counted. As a result, as shown in FIG. 2, it was confirmed that theanine and glutaurine have a fibroblast proliferation promoting effect.
【0017】上記からも明らかなように、本発明に係わ
るグルタミルアミド化合物は、美肌効果に優れているの
みでなく、テアニンはお茶の葉に含まれるアミノ酸であ
って食品添加物としての使用も認められており、また、
グルタウリンは牛の臓器抽出液から分離されている生体
成分であることから、安全性が極めて高いので(現に、
これらの化合物各々をラットに対して1日当り1000
mg/kg以上経口投与したが急性毒性は全く認められ
ず、また、毛刈したモルモットの外皮に適用しても発赤
等の異常は全く観察されなかった。)、化粧料タイプ及
び飲食品タイプのいずれのタイプの美容組成物にも使用
することが可能である。As is clear from the above, the glutamylamide compound according to the present invention not only has an excellent skin effect, but theanine is an amino acid contained in tea leaves and has been approved for use as a food additive. And
Since glutaurine is a biological component separated from bovine organ extract, its safety is extremely high.
Each of these compounds was administered to rats at 1000 per day.
Oral administration of mg / kg or more showed no acute toxicity, and no abnormalities such as redness were observed at all even when applied to the outer skin of shaved guinea pigs. ), Cosmetic compositions and food and drink types.
【0018】そのうえ、増量剤、助剤、その他の化粧品
基剤あるいは食品基剤とも良く馴染み製品化も容易であ
る。本発明の有効成分であるグルタミルアミド化合物を
化粧品基剤あるいは食品基剤に配合する場合、これらを
単独で用いても併用してもよく、更にその他、ビタミン
剤(ビタミンC、ビタミンE)、抗酸化剤(ヒポタウリ
ン、チオタウリン)、蛋白質(コラーゲン、アルブミン
等)等とともに使用しても良い。この場合、たとえば、
テアニンとビタミンCとともに用いるならば、作用機構
の異なる2つのタイプの混合により、美肌効果はより優
れたものになる。また、コラーゲンを更に併用すること
により(グルタミルアミド化合物1部に対して0.01
〜10部、好ましくは0.1〜1部)、化粧料及び飲食
品のいずれのタイプの組成物においても、すぐれた美肌
効果が奏される。Furthermore, it is well compatible with extenders, auxiliaries, and other cosmetic or food bases, and can be easily commercialized. When the glutamylamide compound as the active ingredient of the present invention is blended with a cosmetic base or food base, these may be used alone or in combination. In addition, vitamins (vitamin C, vitamin E), It may be used together with an oxidizing agent (hypotaurin, thiotaurine), a protein (collagen, albumin, etc.) and the like. In this case, for example,
When used in combination with theanine and vitamin C, the combination of the two types with different mechanisms of action will result in better skin effect. Further, by additionally using collagen (0.01 part per 1 part of glutamylamide compound)
10 to 10 parts, preferably 0.1 to 1 part), and any type of composition such as cosmetics and food / beverage can provide an excellent skin effect.
【0019】また、これらは、化粧料、および美容飲食
品として使用されるものであるが、用いる基剤によって
なんら制限されるものではない。したがって一般に化粧
用基剤として用いられている動植物油脂、高級アルコー
ル類、グリコール類、界面活性剤、色素、香料、安定剤
およびその他の成分が自由に使用できる。また、美容飲
食品としても食品基剤として用いられている調味料、酸
味料、甘味料、着色料、保存料、酸化防止剤、着香料お
よびコラーゲンなど、その他の成分が自由にでき、美容
飲料、美容錠菓、美容キャンデー、美容ガム、美容カプ
セル剤等各種タイプの美容飲食品とすることができる。
また、本発明に係わる有効成分の配合等については、有
効成分の安全性に問題がないことからも、特に制限はな
いが、通常の場合は0.01〜20%、好ましくは0.
1〜10%配合するのが望ましい。更に、調整法として
は、当分野における常法が適宜使用できる。These are used as cosmetics and beauty foods and drinks, but are not limited by the base used. Therefore, animal and vegetable fats and oils, higher alcohols, glycols, surfactants, pigments, fragrances, stabilizers and other components generally used as cosmetic bases can be used freely. In addition, other ingredients such as seasonings, sour agents, sweeteners, coloring agents, preservatives, antioxidants, flavoring agents, collagen, and the like, which are used as food bases as beauty foods and drinks, can be freely used. And various types of beauty foods and drinks such as cosmetic tablets, cosmetic candies, cosmetic gums, cosmetic capsules and the like.
The blending of the active ingredient according to the present invention is not particularly limited because there is no problem in the safety of the active ingredient, but it is usually 0.01 to 20%, preferably 0.1 to 0.2%.
It is desirable to mix 1 to 10%. Further, as an adjusting method, a conventional method in the art can be appropriately used.
【0020】化粧料として本組成物を使用する場合、そ
の使用法については、通常の化粧料と異なるものではな
く、通常の場合、目的の個所に、適量を1日あたり1〜
3回塗布すればよい。このような使用法で充分に効果を
発揮し、副作用・毒性の発現は認められない。When the present composition is used as a cosmetic, the method of use is not different from that of ordinary cosmetics.
What is necessary is just to apply three times. Such a method is sufficiently effective, and no side effects or toxicity is observed.
【0021】以下に実施例を記載するが、これらの実施
例は、本発明をこれらに限定するものではなく、具体的
に示すことを目的とするものである。Examples are described below, but these examples are not intended to limit the present invention, but to show concretely.
【0022】[0022]
【実施例1:化粧水】以下に示す処方で化粧水を調製し
た。 1.グリセリン 5.0% 2.プロピレングリコール 4.0% 3.オレイルアルコール 0.1% 4.ポリオキシエチレンソルビタンモノラウリン酸エステル 1.0% 5.ポリオキシエチレンラウリルエーテル 0.5% 6.エタノール 10.0% 7.テアニン 3.0% 8.チオタウリン 1.0% 9.パンテテイン−S−スルホン酸カルシウム 1.0% 10.香料 0.1% 11.防腐剤 適量 12.精製水 74.3%Example 1: Lotion A lotion was prepared according to the following formulation. 1. Glycerin 5.0% 2. 2. Propylene glycol 4.0% Oleyl alcohol 0.1% 4. 4. Polyoxyethylene sorbitan monolaurate 1.0% 5. Polyoxyethylene lauryl ether 0.5% 6. Ethanol 10.0% 7. Theanine 3.0% 8. Thiotaurine 1.0% 10. Pantethein-S-calcium sulfonate 1.0% Fragrance 0.1% 11. Preservative appropriate amount 12. Purified water 74.3%
【0023】[0023]
【実施例2:クリーム】以下に示す処方でクリームを調
製した。 1.MGS−B 1.2 2.BB−5 0.6 3.BB−20 1.2 4.Bees Wax ゴールド 3.0 5.GM−18S 1.0 6.バチルアルコール 18.0 7.CIO 5.0 8.1.3−BG 0.1 9.メチルパラベン 0.1 10.プロピルパラベン 0.1 11.デヒドロ酢酸ナトリウム 0.1 12.グルタウリン 3.0 13.ヒポタウリン 2.0 14.コラーゲン 2.0 15.精製水 62.6 製法:1〜10を85℃に加温溶解し、そこに11〜1
5をまぜて90℃に加温したものを加えホモミキサーで
強く攪拌し、75℃位から攪拌を緩め、30〜35℃で
攪拌を止める。Example 2: Cream A cream was prepared according to the following formulation. 1. MGS-B 1.2 2. BB-5 0.6 3. BB-20 1.2 4. Bees Wax Gold 3.0 5. GM-18S 1.0 6. Bacyl alcohol 18.0 7. CIO 5.0 8.1.3-BG 0.1 9. Methyl paraben 0.1 10. Propylparaben 0.1 11. Sodium dehydroacetate 0.1 12. Glutaurine 3.0 13. Hipotaurine 2.0 14. Collagen 2.0 15. Purified water 62.6 Production method: 1 to 10 was heated and dissolved at 85 ° C.
5 and heated to 90 ° C., and the mixture was stirred vigorously with a homomixer. The stirring was loosened from about 75 ° C., and the stirring was stopped at 30 to 35 ° C.
【0024】[0024]
【実施例3:飲料・1】以下に示す処方で飲料を調製し
た。 1.テアニン 1000mg 2.果糖ぶどう糖液 20000mg 3.クエン酸 200mg 4.コラーゲン 200mg 5.ビタミンC 100mg 6.イノシトール 50mg 7.ニコチン酸アミド 20mg 8.ビタミンB1硫酸塩 5mg 9.ビタミンB2りん酸エステル 5mg 10.ビタミンB6 5mg 11.無水カフェイン 50mg 12.香料 150mg 13.甘味料 適量 製法:1〜13を蒸留水160mlに溶解し、蒸留水を
加えて全量200mlとした後、ろ過し、褐色瓶に無菌
充填した後、加熱滅菌して飲料を製造した。Example 3 Beverage-1 A beverage was prepared according to the following formulation. 1. 1. Theanine 1000 mg 2. Fructose glucose solution 20000 mg 3. 200 mg of citric acid Collagen 200mg5. 5. Vitamin C 100mg 6. Inositol 50 mg 7. Nicotinamide 20 mg Vitamin B1 sulfate 5 mg 9. Vitamin B2 phosphate 5 mg 10. Vitamin B6 5 mg 11. 11. Caffeine anhydrous 50mg Flavor 150mg 13. Suitable amount of sweetener Production method: 1 to 13 was dissolved in 160 ml of distilled water, distilled water was added to make the total amount 200 ml, filtered, aseptically filled in a brown bottle, and then heat-sterilized to produce a beverage.
【0025】[0025]
【実施例4:飲料・2】以下に示す処方で飲料を調製し
た。 1.グルタウリン 500mg 2.果糖ぶどう糖液 20000mg 3.クエン酸 120mg 4.コラーゲン 200mg 5.ビタミンC 100mg 6.ビタミンB1硫酸塩 5mg 7.ビタミンB2りん酸エステル 5mg 8.ビタミンB6 5mg 9.無水カフェイン 50mg 10.香料 150mg 11.炭酸ナトリウム 200mg 12.甘味剤 適量 製法:1〜12を蒸留水160mlに溶解し、蒸留水を
加えて全量200mlとした後、ろ過し、褐色瓶に無菌
充填した後、加熱滅菌して飲料を製造した。Example 4: Beverage-2 A beverage was prepared according to the following formulation. 1. 1. Glutaurine 500 mg 2. Fructose glucose solution 20000 mg 3. Citric acid 120 mg Collagen 200mg5. 5. Vitamin C 100mg Vitamin B1 sulfate 5 mg 7. 7. Vitamin B2 phosphate 5mg Vitamin B6 5 mg 9. 10. Caffeine anhydrous 50mg Flavor 150 mg 11. Sodium carbonate 200 mg 12. Suitable amount of sweetener Production method: 1 to 12 was dissolved in 160 ml of distilled water, distilled water was added to make the total amount 200 ml, filtered, aseptically filled in a brown bottle, and sterilized by heating to produce a beverage.
【0026】[0026]
【実施例5:ドリンク剤・1】以下に示す処方でドリン
ク剤を調製した。 1.テアニン 1000mg 2.チオタウリン 1000mg 3.ローヤルゼリー 200mg 4.コラーゲン 200mg 5.イノシトール 50mg 6.ニコチン酸アミド 20mg 7.ビタミンB1硫酸塩 5mg 8.ビタミンB2りん酸エステル 5mg 9.ビタミンB6 5mg 10.無水カフェイン 50mg 製法:1〜10を蒸留水80mlに溶解し、蒸留水を加
えて全量100mlとした後、ろ過し、褐色瓶に無菌充
填した後、加熱滅菌してドリンク剤を製造した。Example 5: Drink preparation-1 A drink preparation was prepared according to the following formulation. 1. 1. Theanine 1000 mg 2. Thiotaurine 1000 mg Royal jelly 200mg 4. Collagen 200mg5. 5. Inositol 50 mg 6. Nicotinamide 20 mg 7. Vitamin B1 sulfate 5 mg Vitamin B2 phosphate 5 mg 9. Vitamin B6 5 mg 10. 50 mg of anhydrous caffeine Production method: 1 to 10 were dissolved in 80 ml of distilled water, distilled water was added to make the total amount 100 ml, filtered, aseptically filled in a brown bottle, and sterilized by heating to produce a drink.
【0027】[0027]
【実施例6:ドリンク剤・2】以下に示す処方でドリン
ク剤を調製した。 1.テアニン 1000mg 2.パンテテイン−S−スルホン酸カルシウム 500mg 3.ローヤルゼリー 200mg 4.コラーゲン 200mg 5.イノシトール 50mg 6.ニコチン酸アミド 20mg 7.ビタミンB1硫酸塩 5mg 8.ビタミンB2りん酸エステル 5mg 9.ビタミンB6 5mg 10.無水カフェイン 50mg 製法:1〜10を蒸留水80mlに溶解し、蒸留水を加
えて全量100mlとした後、ろ過し、褐色瓶に無菌充
填した後、加熱滅菌してドリンク剤を製造した。Example 6: Drink preparation-2 A drink preparation was prepared according to the following formulation. 1. 1. Theanine 1000 mg 2. Pantethein-S-calcium sulfonate 500 mg Royal jelly 200mg 4. Collagen 200mg5. 5. Inositol 50 mg 6. Nicotinamide 20 mg 7. Vitamin B1 sulfate 5 mg Vitamin B2 phosphate 5 mg 9. Vitamin B6 5 mg 10. 50 mg of anhydrous caffeine Production method: 1 to 10 were dissolved in 80 ml of distilled water, distilled water was added to make the total amount 100 ml, filtered, aseptically filled in a brown bottle, and sterilized by heating to produce a drink.
【0028】[0028]
【実施例7:ドリンク剤・3】以下に示す処方でドリン
ク剤を調製した。 1.テアニン 1000mg 2.ヒポタウリン 1000mg 3.ローヤルゼリー 200mg 4.コラーゲン 200mg 5.イノシトール 50mg 6.ニコチン酸アミド 20mg 7.ビタミンB1硫酸塩 5mg 8.ビタミンB2りん酸エステル 5mg 9.ビタミンB6 5mg 10.無水カフェイン 50mg 製法:1〜10を蒸留水80mlに溶解し、蒸留水を加
えて全量100mlとした後、ろ過し、褐色瓶に無菌充
填した後、加熱滅菌してドリンク剤を製造した。Example 7: Drinks-3 Drinks were prepared according to the following formulation. 1. 1. Theanine 1000 mg 2. Hypotaurine 1000 mg Royal jelly 200mg 4. Collagen 200mg5. 5. Inositol 50 mg 6. Nicotinamide 20 mg 7. Vitamin B1 sulfate 5 mg Vitamin B2 phosphate 5 mg 9. Vitamin B6 5 mg 10. 50 mg of anhydrous caffeine Production method: 1 to 10 was dissolved in 80 ml of distilled water, distilled water was added to make the total amount 100 ml, filtered, aseptically filled in a brown bottle, and sterilized by heating to produce a drink.
【0029】[0029]
【実施例8:ドリンク剤・4】以下に示す処方でドリン
ク剤を調製した。 1.グルタウリン 500mg 2.ヒポタウリン 1000mg 3.ローヤルゼリー 200mg 4.コラーゲン 200mg 5.イノシトール 50mg 6.ニコチン酸アミド 20mg 7.ビタミンB1硫酸塩 5mg 8.ビタミンB2りん酸エステル 5mg 9.ビタミンB6 5mg 10.無水カフェイン 50mg 11.炭酸ナトリウム 200mg 製法:1〜11を蒸留水80mlに溶解し、蒸留水を加
えて全量100mlとした後、ろ過し、褐色瓶に無菌充
填した後、加熱滅菌してドリンク剤を製造した。Example 8: Drinks-4 Drinks were prepared according to the following formulation. 1. 1. Glutaurine 500 mg 2. Hypotaurine 1000 mg Royal jelly 200mg 4. Collagen 200mg5. 5. Inositol 50 mg 6. Nicotinamide 20 mg 7. Vitamin B1 sulfate 5 mg Vitamin B2 phosphate 5 mg 9. Vitamin B6 5 mg 10. 10. Caffeine anhydrous 50 mg 200 mg of sodium carbonate Production method: 1 to 11 were dissolved in distilled water (80 ml), distilled water was added to make the total amount 100 ml, filtered, aseptically filled in a brown bottle, and heat-sterilized to produce a drink.
【0030】[0030]
【実施例9:ドリンク剤・5】 以下に示す処方でドリンク剤を調製した。 1.グルタウリン 500mg 2.タウリン 1000mg 3.ローヤルゼリー 200mg 4.コラーゲン 200mg 5.イノシトール 50mg 6.ニコチン酸アミド 20mg 7.ビタミンB1硫酸塩 5mg 8.ビタミンB2りん酸エステル 5mg 9.ビタミンB6 5mg 10.無水カフェイン 50mg 11.炭酸ナトリウム 200mg 製法:1〜11を蒸留水80mlに溶解し、蒸留水を加
えて全量100mlとした後、ろ過し、褐色瓶に無菌充
填した後、加熱滅菌してドリンク剤を製造した。Example 9: Drink Preparations 5 A drink preparation was prepared according to the following formulation. 1. 1. Glutaurine 500 mg 2. Taurine 1000 mg Royal jelly 200mg 4. Collagen 200mg5. 5. Inositol 50 mg 6. Nicotinamide 20 mg 7. Vitamin B1 sulfate 5 mg Vitamin B2 phosphate 5 mg 9. Vitamin B6 5 mg 10. 10. Caffeine anhydrous 50 mg 200 mg of sodium carbonate Production method: 1 to 11 were dissolved in distilled water (80 ml), distilled water was added to make the total amount 100 ml, filtered, aseptically filled in a brown bottle, and heat-sterilized to produce a drink.
【0031】[0031]
【実施例10:ドリンク剤・6】以下に示す処方でドリ
ンク剤を調製した。 1.グルタウリン 500mg 2.パンテテイン−S−スルホン酸カルシウム 500mg 3.ローヤルゼリー 200mg 4.コラーゲン 200mg 5.イノシトール 50mg 6.ニコチン酸アミド 20mg 7.ビタミンB1硫酸塩 5mg 8.ビタミンB2りん酸エステル 5mg 9.ビタミンB6 5mg 10.無水カフェイン 50mg 製法:1〜10を蒸留水80mlに溶解し、蒸留水を加
えて全量100mlとした後、ろ過し、褐色瓶に無菌充
填した後、加熱滅菌してドリンク剤を製造した。Example 10: Drinks 6 A drink was prepared according to the following formulation. 1. 1. Glutaurine 500 mg 2. Pantethein-S-calcium sulfonate 500 mg Royal jelly 200mg 4. Collagen 200mg5. 5. Inositol 50 mg 6. Nicotinamide 20 mg 7. Vitamin B1 sulfate 5 mg Vitamin B2 phosphate 5 mg 9. Vitamin B6 5 mg 10. 50 mg of anhydrous caffeine Production method: 1 to 10 was dissolved in 80 ml of distilled water, distilled water was added to make the total amount 100 ml, filtered, aseptically filled in a brown bottle, and sterilized by heating to produce a drink.
【0032】[0032]
【実施例11:ドリンク剤・7】以下に示す処方でドリ
ンク剤を調製した。 1.テアニン 1000mg 2.コラーゲン 500mg 3.ビタミンC 500mg 4.ローヤルゼリー 200mg 5.イノシトール 50mg 6.ニコチン酸アミド 20mg 7.ハトムギエキス 20mg 8.ビタミンE酢酸エステル 20mg 9.ビタミンB1硫酸塩 5mg 10.ビタミンB2りん酸エステル 5mg 11.ビタミンB6 5mg 12.コンドロイチン硫酸ナトリウム 50mg 13.無水カフェイン 50mg 製法:1〜13を蒸留水80mlに溶解し、蒸留水を加
えて全量100mlとした後、ろ過し、褐色瓶に無菌充
填した後、加熱滅菌してドリンク剤を製造した。Example 11: Drinks 7 A drink was prepared according to the following formulation. 1. 1. Theanine 1000 mg 2. 500 mg of collagen Vitamin C 500mg 4. Royal jelly 200mg5. 5. Inositol 50 mg 6. Nicotinamide 20 mg 7. Barley extract 20mg Vitamin E acetate 20 mg 9. Vitamin B1 sulfate 5 mg 10. Vitamin B2 phosphate 5 mg 11. Vitamin B6 5 mg 12. 12. Chondroitin sulfate sodium 50 mg 50 mg of anhydrous caffeine Production method: 1 to 13 were dissolved in 80 ml of distilled water, distilled water was added to make the total amount 100 ml, filtered, filled aseptically in a brown bottle, and sterilized by heating to produce a drink.
【0033】[0033]
【実施例12:カプセル】以下に示す処方で美容カプセ
ルを調製した。 1.テアニン 50重量部 2.精製炭酸カルシウム 20重量部 3.ラクトース 178重量部 4.ステアリン酸マグネシウム 2重量部 製法:1〜4を混合し、得られた混合物を250mgず
つ1カプセルに充填し、1カプセル内に50mgのテア
ニンを含有する美容カプセルを調製した。Example 12: Capsules A cosmetic capsule was prepared according to the following formulation. 1. 1. Theanine 50 parts by weight 20 parts by weight of purified calcium carbonate 3. Lactose 178 parts by weight Magnesium stearate 2 parts by weight Manufacturing methods: 1 to 4 were mixed, and the resulting mixture was filled into one capsule in 250 mg portions to prepare a cosmetic capsule containing 50 mg theanine in one capsule.
【0034】[0034]
【発明の効果】本発明によって、皮膚の老化によって起
こるしわ、たるみなどを皮膚の外側のみならず内側から
も予防、改善し、滑らかでしっとりした美肌を保つこと
ができる。According to the present invention, wrinkles and sagging caused by aging of the skin can be prevented and improved not only from the outside of the skin but also from the inside thereof, and a smooth and moist beautiful skin can be maintained.
【図1】本発明によって奏される恒常性維持効果を示
す。FIG. 1 shows the homeostasis effect exerted by the present invention.
【図2】本発明によって奏される繊維芽細胞増殖促進効
果を示す。FIG. 2 shows the effect of promoting fibroblast proliferation exerted by the present invention.
フロントページの続き (51)Int.Cl.6 識別記号 FI A61K 7/48 A23L 2/00 F Continued on the front page (51) Int.Cl. 6 Identification code FI A61K 7/48 A23L 2/00 F
Claims (6)
される化合物を含有することを特徴とする美容組成物。 【化1】 1. A cosmetic composition comprising a compound represented by the following general formula (I): Embedded image
グルタミン酸−γ−モノエチルアミド(テアニン)又は
L−グルタミン酸−γ−スルホン酸エチルアミド(グル
タウリン)であることを特徴とする請求項1に記載の美
容組成物。2. The compound represented by the general formula (I) is L-
2. The cosmetic composition according to claim 1, which is glutamic acid- [gamma] -monoethylamide (theanine) or L-glutamic acid- [gamma] -sulfonic acid ethylamide (glutaurine).
とを特徴とする請求項1又は2に記載の美容組成物。3. The cosmetic composition according to claim 1, further comprising collagen.
品タイプであることを特徴とする請求項1〜3のいずれ
かに記載の美容組成物。4. The cosmetic composition according to claim 1, wherein the composition is a cosmetic type and / or a food and drink type.
とする請求項4に記載の化粧料タイプの美容組成物。5. The cosmetic composition of claim 4, wherein said composition is a skin cosmetic.
する請求項4に記載の飲食品タイプの組成物。6. The food or beverage type composition according to claim 4, wherein the composition is a beauty drink.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9329671A JPH11137212A (en) | 1997-11-14 | 1997-11-14 | Beauty culture composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9329671A JPH11137212A (en) | 1997-11-14 | 1997-11-14 | Beauty culture composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH11137212A true JPH11137212A (en) | 1999-05-25 |
Family
ID=18223974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9329671A Pending JPH11137212A (en) | 1997-11-14 | 1997-11-14 | Beauty culture composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH11137212A (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001093855A1 (en) * | 2000-06-07 | 2001-12-13 | Otsuka Kagaku Kabushiki Kaisha | Skin-moistening compositions and skin-moistening foods |
| WO2005123058A1 (en) * | 2004-06-15 | 2005-12-29 | Osaka Prefectural Government | Antiaging agent |
| WO2006068779A3 (en) * | 2004-12-22 | 2007-07-12 | Avon Prod Inc | Compositions and methods of their use for improving the condition and appearance of skin |
| JP2008024600A (en) * | 2006-07-18 | 2008-02-07 | Naris Cosmetics Co Ltd | Acrolein adduct formation inhibitor, and skin anti-aging external preparation and anti-aging food and drink containing the same |
| JP2009296998A (en) * | 2008-06-17 | 2009-12-24 | Com Institute:Kk | Food composition |
| KR100955236B1 (en) | 2003-06-25 | 2010-04-29 | (주)아모레퍼시픽 | Method for promoting transdermal absorption of deanine and external dermal composition containing same |
| JP2011506429A (en) * | 2007-12-17 | 2011-03-03 | 株式會社アモーレパシフィック | Skin external preparation for promoting proline recycling or beauty food composition containing theanine |
| JP2011115186A (en) * | 2005-11-09 | 2011-06-16 | Ajinomoto Co Inc | Kokumi-imparting agent |
| JP2012010686A (en) * | 2010-07-05 | 2012-01-19 | Suntory Holdings Ltd | Vitamins-containing beverage |
| US9440098B2 (en) * | 2002-08-06 | 2016-09-13 | Naina Sachdev | Antiwrinkle composition and age reversal complex |
| US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
| WO2021084665A1 (en) * | 2019-10-30 | 2021-05-06 | 株式会社 資生堂 | Platelet-derived growth factor (pdgf)-bb production promoter, stem cell stabilizer containing this, and skin anti-aging agent containing these |
| US11110049B2 (en) | 2017-06-23 | 2021-09-07 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
| US11583488B2 (en) | 2020-06-01 | 2023-02-21 | The Procter & Gamble Company | Method of improving penetration of a vitamin B3 compound into skin |
| US11622963B2 (en) | 2018-07-03 | 2023-04-11 | The Procter & Gamble Company | Method of treating a skin condition |
-
1997
- 1997-11-14 JP JP9329671A patent/JPH11137212A/en active Pending
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001093855A1 (en) * | 2000-06-07 | 2001-12-13 | Otsuka Kagaku Kabushiki Kaisha | Skin-moistening compositions and skin-moistening foods |
| JP2004238285A (en) * | 2000-06-07 | 2004-08-26 | Otsuka Chemical Holdings Co Ltd | Composition for moisture retention of skin and food for moisture retention of skin |
| US9440098B2 (en) * | 2002-08-06 | 2016-09-13 | Naina Sachdev | Antiwrinkle composition and age reversal complex |
| KR100955236B1 (en) | 2003-06-25 | 2010-04-29 | (주)아모레퍼시픽 | Method for promoting transdermal absorption of deanine and external dermal composition containing same |
| WO2005123058A1 (en) * | 2004-06-15 | 2005-12-29 | Osaka Prefectural Government | Antiaging agent |
| JPWO2005123058A1 (en) * | 2004-06-15 | 2008-04-10 | 大阪府 | Anti-aging agent |
| WO2006068779A3 (en) * | 2004-12-22 | 2007-07-12 | Avon Prod Inc | Compositions and methods of their use for improving the condition and appearance of skin |
| US7351745B2 (en) | 2004-12-22 | 2008-04-01 | Avon Products, Inc | Compositions and methods of their use for improving the condition and appearance of skin |
| US8304455B2 (en) * | 2004-12-22 | 2012-11-06 | Avon Products, Inc | Compositions and methods of their use for improving the condition and appearance of skin |
| JP2011115186A (en) * | 2005-11-09 | 2011-06-16 | Ajinomoto Co Inc | Kokumi-imparting agent |
| JP2008024600A (en) * | 2006-07-18 | 2008-02-07 | Naris Cosmetics Co Ltd | Acrolein adduct formation inhibitor, and skin anti-aging external preparation and anti-aging food and drink containing the same |
| JP2011506429A (en) * | 2007-12-17 | 2011-03-03 | 株式會社アモーレパシフィック | Skin external preparation for promoting proline recycling or beauty food composition containing theanine |
| JP2009296998A (en) * | 2008-06-17 | 2009-12-24 | Com Institute:Kk | Food composition |
| JP2012010686A (en) * | 2010-07-05 | 2012-01-19 | Suntory Holdings Ltd | Vitamins-containing beverage |
| US11110049B2 (en) | 2017-06-23 | 2021-09-07 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
| US11622963B2 (en) | 2018-07-03 | 2023-04-11 | The Procter & Gamble Company | Method of treating a skin condition |
| WO2021084665A1 (en) * | 2019-10-30 | 2021-05-06 | 株式会社 資生堂 | Platelet-derived growth factor (pdgf)-bb production promoter, stem cell stabilizer containing this, and skin anti-aging agent containing these |
| US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
| US11583488B2 (en) | 2020-06-01 | 2023-02-21 | The Procter & Gamble Company | Method of improving penetration of a vitamin B3 compound into skin |
| US11911498B2 (en) | 2020-06-01 | 2024-02-27 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5925348A (en) | Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin | |
| EP1667699B1 (en) | Compositions comprising lotus extracts and methyl donors | |
| US20020098253A1 (en) | Oral compositions containing lotus | |
| JPH11137212A (en) | Beauty culture composition | |
| JP5102434B2 (en) | Orally administrable composition for improving skin quality | |
| JP4847756B2 (en) | Human β-defensin secretion promoter | |
| JP2007500678A (en) | Use of spermine and / or spermidine in dietary, medical or cosmetic compositions for skin aging | |
| CN101102746B (en) | Skin-condition improving composition comprising vaccinium uliginosum extract and method for preparation thereof | |
| TW201117735A (en) | Collagen production accelerating composition | |
| CN105407866A (en) | Combination of active agents for treating skin aging | |
| WO2009082883A1 (en) | Antiobesity composition | |
| JP2700958B2 (en) | Pharmaceuticals containing bean tea extract as an active ingredient, and foods and cosmetics containing the same | |
| JP3241609B2 (en) | Pharmaceuticals containing bean tea extract as an active ingredient, and foods and cosmetics containing the same | |
| KR101965594B1 (en) | Composition for prevention of losing hair or promotion of growing hair comprising bean extract | |
| KR20230034254A (en) | Leucine derivatives, composition comprising the same, and uses thereof | |
| KR101965595B1 (en) | Composition for prevention of losing hair or promotion of growing hair | |
| JP4703832B2 (en) | Collagen production promoter, estrogen-like agent, collagenase inhibitor, skin cosmetic and food and drink | |
| KR101721022B1 (en) | Composition for comprising adipic acid for improving skin wrinkle or enhancing skin elasticity | |
| KR20090089874A (en) | Oral Compositions Containing EVB and Lycopene | |
| JP3241610B2 (en) | Pharmaceuticals containing bean tea extract as an active ingredient, and foods and cosmetics containing the same | |
| JP2017510630A (en) | Compositions and methods for inhibiting triglyceride synthesis by synergistic combination of botanical formulations | |
| JPWO2007111238A1 (en) | Oral preparation for promoting tissue collagen synthesis | |
| JPH059119A (en) | Oral composition for hair tonic and hair growth | |
| JP2007236308A (en) | Food composition | |
| KR20180003920A (en) | Composition for skin improvement containing liriopesides B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041001 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20060307 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060815 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061013 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20061205 |